Information Update-Safeway Extra Strength Ibuprofen: Labelling Error Could Lead to Serious Harm to Children
(firmenpresse) - OTTAWA, ONTARIO -- (Marketwired) -- 06/06/13 -- Health Canada is advising Canadians that Vita Health Products Inc. is voluntarily recalling all lots of Safeway Extra Strength Ibuprofen Liquid Capsules (400 mg capsules, 50 in a bottle). The recall is due to a labeling error that incorrectly states the product is packaged with a child- resistant bottle and cap.
As there is no child safety mechanism, this presents a risk to children who could open the bottle and ingest the product. The risk of ingestion by children can result in ibuprofen overdose and serious health consequences including, seizures, kidney failure, heart problems and coma. Early signs of overdose include nausea, vomiting, lethargy and abdominal pain.
Vita Health Products Inc. is requesting that retailers immediately stop sale of this product and return their products to the company. Consumers who have any of these products in their possession should return the product to the place of purchase.
Vita Health Products Inc. has informed Health Canada that as of June 6, 2013, there had been no adverse events reported concerning this product. As well, Health Canada has not received any adverse reactions reports.
Health Canada is monitoring the recall by Vita Health Products Inc. Should new information be identified, Health Canada will continue to provide an update to Canadians.
Health Canada reminds Canadians who have concerns about these products to consult with their health care practitioner. Consumers may call the company at 1-(800)-665-8820, Monday-Friday 9:00 am - 5:30 pm EST for further instruction. Media wishing more information should contact Brian Ellis of Vita Health Products Inc. at: 1-804-675-8140.
The information contained in this chart will help consumers identify if they are in possession of the affected product.
How to report side effects to health products:
- Call toll-free at 1-866-234-2345
- Visit MedEffect Canada's web page on for information on how to report online, by mail or by fax.
Egalement disponible en francais
Contacts:
Media Inquiries:
Health Canada
613-957-2983
Public Inquiries:
613-957-2991
1-866-225-0709
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.06.2013 - 12:31 Uhr
Sprache: Deutsch
News-ID 1234663
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
OTTAWA, ONTARIO
Phone:
Kategorie:
Government & Administration
Anmerkungen:
Diese Pressemitteilung wurde bisher 136 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Information Update-Safeway Extra Strength Ibuprofen: Labelling Error Could Lead to Serious Harm to Children
"
steht unter der journalistisch-redaktionellen Verantwortung von
Health Canada (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
